Competent cells Market Worth 2,318.6 Million USD by 2023Published On: February 14, 2018
The global competent cells market will grow at a CAGR of 10% from 2018 to 2023 to reach USD 2,318.6 million by 2023, according to this latest publication from Meticulous Research®. The global competent cells market is driven by various factors such as growing demand for recombinant proteins & molecular cloned products, advancement in molecular cloning research with emergence of new technologies, and rising government initiatives and funding for life science research.
Key Opportunities and Challenges for the Competent cells Market
Emerging economies such as Latin America, Asia Pacific, & Africa provides significant opportunities for various stakeholders in this market. However, increasing recombinational and cloning based applications simultaneously enhance the need for maintenance of laboratory transformation parameters; thereby challenging the growth of competent cells market to some extent.
Browse in-depth Report on https://www.meticulousresearch.com/product/competent-cells-market-forecast-2023/
Key Market Segments to Watch
The global competent cells market is mainly categorized by type (cloned competent cells, Agrobacterium tumefaciens competent cells, expression competent cells), treatment (chemically competent cells and electrocompetent cells), application (cloning, protein expression, others), end user (pharmaceutical & biotechnology industry, academics & research institutes, and contract research organizations), and geography.
On the basis of type, cloned competent cells commanded the largest share in the global competent cells market in 2017, mainly due to their rising adoption in research with increasing feasibility of genetic therapy, need for rapid diagnosis & treatment, favorable government support for cloning based research in various countries, and rising availability of sophisticated instruments and technology.
On the basis of treatment, chemically competent cells held the largest share in the global competent cells market in 2017. This was mainly attributed to the rising need for cost effective experimental protocol with growing demand for recombinant proteins and molecular cloned products, and rising intensity of cell based research. Chemically competent cells have been commonly used for transformation and vector based molecular cloning experiments because the treatment of competent cells through chemicals is very simple, faster, cost effective, and does not require any specialized equipment.
On the basis of application, cloning accounted for the largest share in the global competent cells market in 2017. The large share of this market is mainly attributed to various advancements in recombinant technology, increasing government support for cloning based research, and rising R&D funding for cell based research.
Based on end user, pharmaceutical and biotechnology industry commanded the largest share in the global competent cells market in 2017, mainly due to higher adoption of competent cells by pharmaceutical & biotechnology companies with growing demand for molecular cloning with advancements in the cloning technologies, and rising investments in research & development to fulfill the demand for protein based therapeutics.
Key players in the global market
The key players in the global competent cells market are Thermo Fisher Scientific, Inc., Agilent Technologies, Inc., Bio-Rad Laboratories, Inc., Merck & Company, Inc., Illumina, Inc., Promega Corporation, New England Biolabs, OriGene Technologies, Inc., Zymo Research Corporation, Scarab Genomics, LLC, Meridian Bioscience, Inc., Delphi Genetics S.A., Qiagen N.V., Cell Applications, Inc., GenScript Biotech Corporation, and Takara Holdings Inc.
Key questions answered in the report-
- Which are the high growth market segments in terms of product type, treatment, application, end user, and regions/countries?
- What is the historical market for competent cells across the globe?
- What are the market forecasts and estimates from the period 2018-2023?
- What are the major drivers, restraints, opportunities, and challenges in the global competent cells market?
- Who are the major players in the global competent cells market and what share of the market do they hold?
- Who are the major players in various countries and what share of the market do they hold?
- What are the competitive landscapes and who are the market leaders by sub-region in the global competent cells market?
- What are the recent developments in the global competent cells market?
- What are the different strategies adopted by the major players in the global competent cellsmarket?
- What are the geographical trends and high growth regions/ countries?
- Who are the local emerging players in the global competent cells market and how do they compete with the global players?
About Meticulous Research®
Meticulous Research® is founded in 2010 and incorporated as Meticulous Market Research Pvt. Ltd. in 2013 as a private limited company under the Companies Act, 1956. Since its incorporation, the company has become the leading provider of premium market intelligence in North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa.
With the meticulous primary and secondary research techniques, we have built strong capabilities in data collection, interpretation, and analysis of data including qualitative and quantitative research with the finest team of analysts. We design our meticulously analyzed intelligent and value-driven syndicated market research reports, custom studies, quick turnaround research, and consulting solutions to address business challenges of sustainable growth. Meticulous Research® produces global reports and custom studies for North America, Europe, Latin America, Asia-Pacific, and the Middle East and Africa regions. These reports are used by our clients for marketing and strategic planning in various sectors.
Contact Sales- +1-646-781-8004
Connect with us on LinkedIn- https://www.linkedin.com/company/meticulous-research
Connect with us on Twitter- https://twitter.com/MeticulousR123